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Structural investigation and compression of a co-crystal of indomethacin and 
saccharin. 
Lauren E. Connor,*ab Antony D. Vassileiou,d Gavin W. Halbert,a,c Blair F. Johnstona, c-e and Iain D.H. 
Oswald*a 
The co-crystalline structure of the non-steroidal, anti-inflammatory indomethacin with the non-toxic, 
Generally Regarded As Safe (GRAS) sweetener component saccharin was investigated up to 6.33 GPa 
using a Diamond Anvil Cell (DAC). Single crystal X-ray diffraction measurements show that the co-
crystal remains in the same triclinic, P-1, phase throughout the compression with a significant 
reduction in void space (155.69 to 55.61Å3). Information on the response of different types of 
intermolecular interactions to external force at the same time is enabled by the use of a co-crystal. 
We have rationalised that the length and compression rate of the saccharin amide dimer in the co-
crystal is caused by the dimer sitting in a ‘pocket’ surrounded by the indomethacin framework. This 
framework reduces the effects of molecular packing on the dimer allowing for an ideal hydrogen 
bonding geometry. 
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Introduction 
Co-crystallisation is a branch of solid state modification that has 
been of growing interest in the energetic material, ferroelectric 
and pharmaceutical industry in recent years.1–6 Much akin to its 
fellow branch of solid state modification, salt formation, co-
crystallisation is the incorporation of two or more species in the 
crystalline structure. Co-crystallisation has a much greater 
scope due to the use of neutral coformers and the lack of 
requirement for an ionisable group.7 Crystal engineering 
modifications are sought to explore a few avenues of interest 
but one common interest spanning across all industries is the 
alteration of the physicochemical properties.8,9 A change in the 
physicochemical properties could also mean a change in the 
mechanochemical properties and functionality of the singular 
component material on the larger, potentially tangible, product 
scale. Interesting macroscopic mechanical properties have been 
observed in co-crystals of vanillin,10 caffeine,11 and 
chlorophenol derivatives12 where extreme flexibility in crystals 
have been observed. These co-crystals can be physically bent 
(exhibiting plastic deformation) due to the anisotropy of the 
interactions between molecules where strong and weak 
interactions are present perpendicular to each other. These 
materials still show a crystalline nature even after 
deformation.11,13 To fundamental scientists, co-crystallisation 
offers something of value on the molecular scale; the potential 
to investigate intermolecular interactions which may not have 
occurred within the structure of a singular component. By 
adding another component to the structure there are new 
synthons to analyse which open up a wealth of new molecular 
opportunities. In understanding these competing interactions 
we can begin to understand how the molecules self-assemble 
into the co-crystalline form. Co-crystals may contain 
components that have a large difference in the number of 
atoms hence the balance of contribution of different 
intermolecular interactions in these systems can be quite 
different to pure systems. Whilst in many systems hydrogen 
bonding interactions are the linkage of the two components in 
the crystal structure, weaker dispersive forces can play a 
significant role in the overall energy of the structure. By 
understanding the basic fundamentals of the structure, the 
properties can be explained and possibly controlled but even 
when we have understood a system invariably polymorphism 
arises. A recent study by Cruz-Cabeza et al.14 has shown through 
database mining that polymorphism in co-crystalline phases are 
equally as common as with pure components. The initial 
concept of co-crystallisation was to try to inhibit or reduce the 
propensity for polymorphism but this has proved to be not the 
case.15–17 Considering this realisation, we have set about to use 
high pressure to evaluate effects of pressure on co-crystalline 
systems. Using pressure we can: i) survey the thermodynamic 
stability of ambient pressure forms;18–21 ii) access to metastable 
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polymorphs;22–24 and iii) investigate the response of hydrogen 
bonds with respect to pressure.25–31  
Indomethacin is a Non-Steroidal Anti-Inflammatory (NSAID) 
that is known for its ability to reduce fever, pain, stiffness and 
swelling and can be prescribed for migraines. There are 10 
different multi-component forms found in the Cambridge 
Structural Database (CSD).32 In its pure form, Indomethacin has 
been well-characterised under ambient and high-pressure 
conditions. Under ambient conditions there are three 
polymorphs α-γ; a fourth δ-form is a hydrate. At ambient 
pressure, the -form is the most stable form which was 
demonstrated by Okumura et al. where they slurried the -form 
of indomethacin in ethanol over the course of four days and 
observed that transformed to the -form. At high pressure, 
however, the behaviour of the slurry changes. At a modest 
pressure of 0.4 GPa, the transformation of the -form to the -
form is reversed indicating that whilst metastable at ambient 
pressure, the -form is more stable at higher pressures.33 A 
compression of the -form to 0.4 GPa without ethanol solvent 
did not reveal any polymorphic transformation which reveals 
the significance of the solvent in mediating these pressure-
induced phase transitions.34  
Given the rich behaviour of Indomethacin, we have chosen 
to investigate the co-crystal of indomethacin and saccharin 
(INSA) under high-pressure conditions. It is a well-characterised 
system known to have altered physicochemical properties 
compared with indomethacin itself such as a higher solubility 
and bioavailability.35,36 In the previous studies, there is no 
indication of any polymorphism. In the co-crystal, the 
indomethacin and saccharin molecules hydrogen bond with 
themselves allowing both types of hydrogen bond (carboxylic 




A Merrill-Bassett diamond-anvil cell (DAC) with an opening 
angle of 80 was used for the experiments. The opposing gem-
quality diamonds with a culet size of 600m were used with 
Boehler-Almax tungsten carbide backing seats. The DAC sample 
chamber was a 300m diameter hole drilled into a tungsten 
10mm x 10mm square gasket pre-indented to a thickness of 
90m (Almax Easylab Driller). A ruby sphere of approximately 
15m diameter was loaded into the chamber along with the 
sample to measure the pressure in situ via the ruby 
fluorescence technique.37 A Horiba XplorA Raman spectrometer 
equipped with a 532nm laser was used to measure the ruby 
fluorescence.  
Co-crystal formation 
A 1:1 stoichiometric co-crystal of indomethacin and 
saccharin (INSA) was grown from ethyl acetate via a small batch 
evaporative co-crystallisation (35.7mg of indomethacin to 
18.32mg of saccharin in 1 ml). A crystal of dimensions 0.5mm x 
0.3mm x 0.25mm was used to determine the crystal structure 
at ambient pressure. 
Diamond anvil cell preparation 
For the compression study a prismatic crystal of the co-crystal 
was loaded into the DAC with petroleum ether (40:60) acting as 
the pressure-transmitting medium to allow for hydrostatic 
compression; the initial sealing of the cell introduced a pressure 
of 0.55GPa. Single crystal X-ray diffraction data were collected 
with the DAC in a single orientation throughout the study, 
attempts to improve on the data completeness by collecting a 
second orientation and merging the data with the initial dataset 
failed to provide a significant improvement in the completeness 
or structure refinement. Due to a pressure jump from 0.55GPa 
to 3.33GPa, another cell was loaded in the same manner with 
another crystal. A dataset was taken at 1.66GPa to fill the gap in 
the compression study. 
Single-crystal X-Ray diffraction 
Ambient crystal collection, processing and refinement 
X-ray diffraction intensities were collected from a sequence of 
six scans at 293K using a Bruker APEX II CCD diffractometer with 
an Incotec IS microsource (Mo K radiation,  = 0.71073 Å). 
Data were indexed and then integrated using SAINT as 
incorporated in the APEX II software.38 An absorption correction 
was applied using SADABS.39 The crystal structure at ambient 
pressure was refined within OLEX240 (F2) using the atomic 
coordinates from the Cambridge Structural Database (CSD 
refcode UFERED). All heavy atoms were anisotropically refined. 
Hydrogen atoms were placed in calculated positions and 
constrained to ride their parent atom as per procedure in 
OLEX2. The crystallographic data can be found in Table S1. 
 
Compression study collection, processing and refinement 
The high-pressure data were collected and treated in a 
similar manner to the ambient procedure described above. X-
ray diffraction intensities were collected from a sequence of 
twelve scans at 293K following the procedure described by 
Dawson et al. Data were indexed and then integrated using 
SAINT in conjunction with dynamic masks.41 An absorption 
correction was applied in two stages using both SHADE and 
SADABS, respectively.39,42 Known coordinates from the ambient 
pressure model were used as a starting model for the 
refinement. For high-pressure datasets the heavier atoms (S-35 
and Cl-1, see Fig 1) were refined anisotropically and the 
remainder of the heavy atoms were refined isotropically due to 
the limited data and large number of atoms. Additionally, 
distance restraints were applied to the high pressure structures 
of INSA using distances taken from a Mogul geometry search of 
the CSD as implemented in Materials Mercury.43 The geometry 
of the phenyl rings were constrained. Hydrogen atoms were 
placed in calculated positions and constrained to ride their 
parent atoms. The refined model from each pressure point was 
used as a starting model for each subsequent model. The 
crystallographic data can be found in Table S1. 
 
H-bonding length distribution in Cambridge Structural Database 
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The CSD version 5.39 (March 2018 + 3 updates until May 2018) 
was used along with Conquest Version 1.21 to search for H-
bond distributions.32 The first search for crystal structures with 
an intermolecular (carboxylic acid) O-H…O dimer contact length 
between 2.45Å and 2.75Å produced 4977 refcodes. The second 
search for crystal structures with an intermolecular (amide) N-
H…O dimer contact length between 2.65Å and 3.1Å produced 
7600 refcodes. Both searches excluded all errors, polymeric, ion 
and powder structures and considered only organic molecules 
with 3D coordinates determined. An additional constraint of no 
alkali metals was used since the software’s native definition of 
an organic molecule includes these species. 
Using CSD Python API, a restricted CSD entry list of 
compounds under high-pressure conditions was produced 
(2454 CSD refcodes). Only refcodes with pressure explicitly 
stated in the experimental conditions were taken into account. 
The exclusion parameters previously described were also 
applied here for consistency with the original search. The 
restriction narrowed the results of the carboxylic acid dimer 
search to 45 refcodes, equating to 12 compounds, and the 
amide dimer search to 30 refcodes, equating to 5 compounds. 
 
Dimer potential energy calculations 
The coordinates of the saccharin dimer were taken from the 
ambient pressure structure of saccharin (CSD refcode 
SCCHRN06). The dimer was extracted from the crystal structure 
using Avogadro44 and 19 different D…A distances were 
formulated for input into Gaussian0945 using Pixelc.46–48 A basis-
set of MP2/6.31G** was chosen to calculate the dimer energy 
and the lowest energy was set to zero. 
Results and Discussion 
Structure 
The crystals grown from ethyl acetate were of similar size and 
consistent in crystal habit indicating that the batch were all the 
same material. The unit cell information was consistent with 
those found in the Cambridge Structural Database (CSD) for the 
1:1 stoichiometric co-crystal of INSA (CSD refcode: UFERED) 
(Fig. 1).32,35 INSA crystallises in space group P-1 with one 
molecule of each component in the asymmetric unit. 
 
Figure 1: The asymmetric unit of Indomethacin(right):saccharin(left) co-crystal 
with numbering scheme (hydrogen atoms omitted for clarity). The colours of the 
elements are consistent throughout paper unless otherwise stated. (carbon, grey; 
oxygen, red; sulphur, yellow; nitrogen, blue; chlorine, green; hydrogen, white, 
shown in Fig. 2) 
Indomethacin is an indole derivative with a chlorobenzoyl ring, 
methoxy group and carboxylic acid presenting opportunities for 
hydrogen bonding with suitable donors. Saccharin, the artificial 
sweetener, is a dioxobenzothiazol and is considerably smaller 
than indomethacin. The crystal structure of INSA consists of 
dimers of each component linked through close interaction 
between the NH of saccharin and C=O of the indomethacin. 
Utilising this close interaction, the two components form a 
chain along the b-axis as shown in Fig. 2. Neighbouring chains 
run parallel to each other interlocking through non-directional 
CH-π interactions between the chlorobenzoyl rings (Fig. 3). 
Pixel calculations47,49 of the INSA co-crystal, reveal that the 
strongest molecule to molecule interactions are those 
associated with the hydrogen bonded dimers; the carboxylic 
acid dimer between indomethacin molecules (total 83.6kJmol-1; 
O16…O17’ 2.677(3) Å) and the sulphonamide dimer between 
the saccharin components (total 60.2 kJmol-1; N26…O28’ 
2.884(3) Å). The third and fourth notable interaction can be 
attributed to a / interaction (indomethacin to saccharin, total 
-50.3 kJmol-1; dispersion -51.1 kJmol-1) and a CH/ interaction 
(indomethacin to indomethacin, total -46.1 kJmol-1; dispersion -
53.6 kJmol-1) respectively. These latter two molecule-molecule 
interactions are surprisingly strong given that they are 
predominantly comprised of dispersive forces. The bicyclic  
 
Figure 2: A section of the structure of indomethacin and saccharin with 
hydrogen bonding contacts shown. Depicted a and b indicate a strong 
carboxylic acid dimer formed by indomethacin molecules and the dimer 
between saccharin molecules, respectively. 
moieties of the indomethacin and saccharin are well-aligned 
which contributes significantly to the attractive dispersive 
forces. In this instance, the total energy of the interaction is 
nearing the typical energies for hydrogen-bonded interactions. 
The bicyclic indole moiety of the indomethacin interacts 
through a CH…π interaction with a neighbouring indomethacin 
molecules where the chlorobenzoyl of the second 
indomethacin is in an edge-to-face arrangement with the 
symmetry equivalent molecule (-x, -y, -z). 
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Figure 3: Section of two hydrogen bonded chains running parallel along the b-axis 
in the ab plane interlocking through a / interaction between indomethacin and 
saccharin (i) and a CH-π interaction between indomethacin molecules (ii) shown 
in the blackened molecules. 
Compression study 
The co-crystal undergoes a 20% decrease in volume from 
1210.1Å3 at ambient pressure to 974.5Å at 5.06 GPa (Figure 4). 
The 3rd order Birch-Murnaghan Equation of State gives a bulk 
modulus (K0) of 15(3) GPa with a V0 = 1199(12) Å3 and K’ = 
4.6(12). A further dataset taken at 6.33 GPa was of such poor 
quality that no structural information could be derived even 
after collecting data in a different orientation, however, the unit 
cell information was used in the determination of the bulk 
modulus. The decrease in the quality of the crystal is attributed 
to reaching the limit of the hydrostatic medium. 
 
 
Figure 4: a) Unit cell volume of INSA as a function of pressure. The 3rd order Birch-
Murnaghan Equation of State (K0 = 15.46 (13) GPa, V0 = 1199.35 (4) Å3, K’ = 4.49 
(2)) is plotted alongside the data (line) (EoSfit 7)50 , (b) Normalised unit cell lengths 
as a function of pressure. The errors on each of the measurements is smaller than 
the symbol. 
The unit cell axes display a smooth compression with decreases 
of 6.5%, 10.8% and 2.7% in the a-, b- and c-axis respectively (Fig. 
4). The large decrease in the b-axis is explained by the analysis 
of the void space in the structure and the absence of strong 
interactions between the indomethacin and saccharin dimers. 
Figure 5 shows the voids present in the structure at ambient 
pressure with large pockets of space between the 
chlorobenzoyl rings of neighbouring indomethacin molecules 
translated along the same chain. Over the course of the 
compression, these voids decrease from 17.8% of the unit cell 
to 4.7% at 5.06 GPa (Fig. 5; Table 1). Even at the highest pressure 
of 6.33 GPa, the unit cell parameters that could be observed 
from the deteriorating diffraction pattern indicated the 
retention of this phase hence the void space will have 
compressed even further. Using PASCal51 the greatest direction 
of compression has a large component of the b-axis [0.4317 
0.8653 -0.2546] but the overall direction of this greatest strain 
is in the direction of the / and CH/ interactions described 
earlier. The other two axes of strain are perpendicular to this 
and approximately perpendicular to each other. It is apparent 
that the voids are present in all three dimensions in the crystal 
structure and are partly accountable for the resistance to any 
phase transformation in the system i.e. in every direction 
compression can take place without necessary rearrangement 
of atoms to relieve repulsion between atoms. The small pocket 
of void space, in Fig. 5d, is ‘protected’ from compression to 
some extent due to the size and bulkiness of the indomethacin 
molecule with any reduction in the pocket necessitating 
compression of molecular groups substantially inside the sum 
of the van der Waals radii.  
 One of the significant developments over the compression 
is the change in the interaction energy between the 
indomethacin molecule and the saccharin molecule (x-1, 1+y, 
1+z). The close contact, and only real interaction between the 
molecules, is between the hydroxyl oxygen and carbonyl oxygen 
atoms indomethacin and saccharin respectively. The interaction 
between these molecules becomes highly repulsive increasing 
from 1.2 kJmol-1 at ambient pressure to 7.2 kJmol-1 at 5.06 GPa. 
There are very few attractive forces between the molecules 
hence the repulsion term dominates the molecular interaction. 
One of the key aspects to this study was to investigate how 
intermolecular interactions change as a function of pressure. 
There have been a large number of studies of materials under 
pressure but the types of hydrogen bond that have been probed 
is not particularly diverse nor have there been a significant 
number of studies of particular hydrogen bonds except for, 
perhaps, ammonium-carboxylate interaction, due to studies of 
amino acids.29,52–58 INSA exists as a co-crystal with only 
homomeric hydrogen bonding interactions (carboxylic acid and 
amide dimers). We probed the CSD for similar hydrogen 
bonding interactions to those in our system. Analysis of 
hydrogen bonding distributions of similar dimer interactions are 
presented in Fig. 6. Due to the limited data from the high-
pressure experiment, the hydrogen bonding distances are 
Donor…Acceptor (D…A) distances. In terms of the carboxylic acid 
dimer, the mean distance is 2.643 Å. At ambient pressure, 
carboxylic acid dimer of INSA (2.6803(18) Å) is slightly above this 
value, however on compression to 5.06 GPa the dimer reduces 
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by 7% to 2.496(12) Å, below those observed in the database 
(Table S2). 
Table 1: Percentage of the unit cell occupied by void space at each pressure. The 
probe radius was set to 0.5Å with 0.1 grid spacing.  
 










Figure 5: The structure of the unit cell down the a-axis (a). The void space at 0.0001 
GPa (b), 3.33 GPa (c), and 5.06 GPa (d) obtained by using probe radius of 0.5Å with 
high definition of 0.1Å. 
The majority of the database structures are at ambient 
pressure but the lower end of the distribution has been used in 
previous work to show that a phase transition may be imminent 
during compression studies.59 Perhaps a more instructive 
comparison would be with other pressure studies to see if, 
despite changes to molecular connectivity, the hydrogen bonds 
are compressed to a similar level. Restricting the database to 
those refcodes that have pressure explicitly stated in their 
experimental conditions, there are 2454 refcodes reported in 
the CSD. 45 of these refcodes contain a carboxylic acid dimer 
contact. R,S-Ibuprofen60 and acetylenedicarboxylic acid61 are 
the only observations of a carboxylic acid dimer compression 
study in the database, via single crystal diffraction, that extends 
to the pressures that have been investigated here. In general, 
the other entries are mostly individual collections at particular 
pressures hence do not give information on how hydrogen 
bonds change with respect to pressure. Notable studies are 2+2 
cycloaddition reactions of 3-(2,5-difluorophenyl)prop-2-enoic 
acid (HESREF)62 and  3-(2,6-difluorophenyl)acrylic acid63 under 
high pressure conditions that have been studied to 0.9 and 2.1 
GPa respectively. The hydrogen bonded dimer in ibuprofen 
compresses to a similar value to our INSA example and at 4 GPa 
it is observed at 2.549 Å (cf. 2.529(10) Å for INSA at 4.06 
GPa)(Table 3). Further compression of INSA to 5.06 GPa reduces 
the hydrogen bond further to 2.496(12) Å to be amongst the 
shortest reported in the database. In the case of 
acetylenedicarboxylic acid the hydrogen bond is disordered but 
the O…O distance reduces form 2.691 Å to 2.557 Å at 4.85GPa 
before undergoing a phase transformation at 5.2 GPa that 
increases the O…O distance to 2.602 Å.  
The distribution of the amide dimers in the CSD are shown 
in Fig 6 compared with the values observed in our study. The 
mean distance of the amide dimer in the CSD is 2.931 Å with our 
model showing a dimer distance of 2.8855(19) Å. As a 
comparator, pure saccharin has a dimer contact of 2.818 Å. On 
compression to 5.06 GPa the hydrogen bond reduces by 8% to 
2.655(10) Å again approaching the lowest values observed in 
the CSD. By restricting the CSD to show structures that have 
been studied under compression conditions (multiple datasets 
over a wide pressure range), there are only thirty refcodes 
observed pertaining to five molecules. Two polymorphs of 2-
oxopyrrolidineacetamide (piracetam),64 2-hydroxybenzamide 
(salicylamide)59 and a compression of two polymorphs of anti-
diabetic, tolazamide.65  
Figure 6: Histograms showing the distribution of O-H…O and N-H…O distances 
reported in the CSD with markers for the distances reported in the compression 
of INSA at ambient and the highest pressure dataset refined. 
 Figure 7 shows the changes in the hydrogen bonding in INSA 
compared with the dimer distances from other pressure studies 
of amides. The relative compression in each of these systems is 
comparable with a suggestion that the dimers in INSA and 
tolazamide are compressed a little faster. The reason behind 
this slight change in behaviour is potentially a combination of 
both the packing of the compounds and respective positioning 
of the hydrogen bonds in the structure. Both amide dimer 
contacts for piracetam64 and salicylamide59 are involved in a 
second hydrogen bonding interaction in an opposing direction 
within the structure which will aid in stabilising the amide dimer 
against shortening as a result of compression. Piracetam dimers 
form a hydrogen bond to the carbonyl of another neighbouring 
dimer unit in each direction, stabilising the central dimer. 
Piracetam undergoes a subtle phase transition after 0.45 GPa 
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from Form II to Form V which is the reason for the change in 
compression behaviour but the hydrogen bonding remains the 
same. The driving force for this transition is the reduction of 
voids in the structure. Salicylamide packs to form a channel of 
hydrogen bonding enabled by a screw axes. Each molecule in 
the dimer bonds perpendicularly bonds to another molecule, 
forming channels of hydrogen bonding. Piracetam and 
salicylamide also possess a layered structure where the 
hydrogen bonding is situated within the layer. The principal axis 
of strain was calculated to be approximately perpendicular to 
these layers in each case signifying that the main compression 
of the system comes from reducing the spacing between them 
hence the hydrogen bonding (in the layer) will be less impacted.  
 Tolazamide65 polymorph II shows a similar rate of 
compression to INSA. The tolazamide structure exists as 
hydrogen-bonded dimers in layers with - interactions 
between the layers. Like INSA, the amide dimer contact is not 
involved in any other hydrogen bonding therefore may be more 
susceptible to compression. Comparatively, the dimer observed 
in INSA is much closer at all pressure points than previous high 
pressure studies of piracetam, salicylamide, and tolazamide but 
is close to the average distance as observed in the database. The 
dimer in saccharin itself lies at ~2.80 Å depending on the 
temperature of the study. The other compounds under study 
possess longer NH…O hydrogen bonding parameters at ambient 
pressure suggesting that the hydrogen bond interaction is 
lengthened to accommodate the packing of the molecules to a 
greater extent than in INSA. The packing indexes for each 
compound were calculated in Platon66 and found to be 73.0 %, 
71.0 %, 70.5 %, 68.3 % and 68.2 % for piracetam, INSA, 
saccharin, tolazamide and salicylamide, respectively. Piracetam 
packs more efficiently than the rest but the nitrogen of the 
amide dimer is involved in another N-H…O amide contact using 
the second hydrogen of the amide in the opposite direction 
which may serve to weaken and lengthen the dimer h-bond. 
Tolazamide and salicylamide have comparable lower packing 
indexes. Tolazamide is a relatively bulky structure that is more 
than double the molecular mass (311.4 g/mol) of salicylamide 
(137.1 g/mol). In the compression comparison Tolazamide was 
the only other structure with an amide dimer not involved in 
other hydrogen bonding that may allow a faster rate of 
compression. At ambient pressure, however, sterics will affect 
the packing of this structure inducing the 105 angle at the 
sulphonamide group. In contrast, the low packing index for 
salicylamide is not due to sterics but as a result of the 
channelled hydrogen bonding and layered structure. INSA and 
saccharin itself possess an amide dimer that is free from other 
hydrogen bonding interactions. The pure substance is also a 
layered structure with a layer of hydrogen bonding with slip 
planes either side. The hydrogen bonding is supported by the 
close packing of the rings within the layer providing a stable 
environment for a short dimer contact.  
A potential reason for the saccharin dimer being slightly 
longer in INSA is that the packing of the solid in INSA will be 
dominated by the packing of the indomethacin molecules due 
to its size. The saccharin dimer is in a pocket bookended by two 
indomethacin molecules. The saccharin dimer is not bound by 
the close packing of similar molecules (in the case of the pure 
compound) hence may be lying at an ideal H-bonding distance 
for a ‘gas-phase’ dimer within this pocket. To support this 
hypothesis, dimer calculations were performed on the 
saccharin dimer at various set distances to probe the potential 
energy well. Figure 7b shows the plot of the dimer energy versus 
distance for the saccharin dimer. Hydrogen-bonding values for 
the pure compound (SCCHRN06) and the cocrystal (INSA) are 
indicated.  As can be observed the potential energy well is 
rather shallow and the h-bonding distances for both 
environments sit in the minimum. There is no energy penalty 
over the small separation distance hence we believe that the 
packing of the molecules in the immediate environment permits 
the saccharin dimer in the co-crystal to lie at a further distance. 
The low energy penalty for compressing this h-bond will 
facilitate its compression. 
Conclusion 
In this paper we have investigated the co-crystal of 
indomethacin and saccharin and its intermolecular interactions. 
The investigation of the continuous compression of the co-
crystal showed no phase transition however there were some 
interesting points to note from the exploration of the structure 
on compression. Surprisingly, there are few compression 
studies involving acid or amide dimers in the CSD. A 
comparative study between INSA and other compression 
studies in the database with an amide dimer motif revealed that 
the amide bond compression was dependant on whether the 
amide was involved in further hydrogen bonding through the 
second amide hydrogen. The compression rate was slower for 
systems involving amide dimers with a second hydrogen 
bonding interaction but this is likely due to the extension of the 
hydrogen-bonding to form layered structures where the 
compression is maximised between layers rather than in the 
layer hence lower compression of the dimer. In comparison, 
INSA possesses a shorter amide dimer contact length and has a 
fast rate of compression that can be linked to the shallow 
potential energy well of the saccharin amide dimer. In terms of 
application to pharmaceutical development, this study provides 
a detailed understanding of how the co-crystal compresses and 
where the principal axes of strain lie in relation to the molecular 
species and intermolecular interactions. These observations are 
invaluable for the modelling of tabletting processes. How 
molecular species behave on compression can be utilised to 
improve models such that they may become predictive. In the 
future, by evaluating this relationship and encoding it, one may 
be able to design solids through crystal engineering to be more 
or less compressible in a particular direction thereby tuning the 
physical properties of the material to suit pharmaceutical 
processing. 
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Figure 7: a) Plots showing how the length of piracetam (form II: half symbol & form 
V: filled symbol), INSA, tolazamide, and salicylamide’s N-H…O amide dimer 
respond to pressure. b) The saccharin dimer single point energy at increasing 
hydrogen bonding distance (N…O distance). The calculation was performed at 
MP2 6-31G** basis set. The Morse fit to the data provided refined parameters of 
De (depth of well) = 62.8(5) kJmol-1, a (width of well) = 1.502(10) Å-1, and Re 
(equilibrium distance) = 2.852(3) Å. 
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